Pancreatic Cancer Research

ResearcherUniversidad de GranadaNo recent work listed

Kevin Doello González

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1061-6808; OpenAlex author ID A5034733928. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study. Co-author DOI 10.3390/cancers13133169↗
  2. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment. Co-author DOI 10.2174/1389450121666200703195229↗
  3. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview. Co-author DOI 10.20892/j.issn.2095-3941.2019.0252↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Francisco Quiñonero · 3 shared papers, 2019–2021 · strength 0.35
  2. Gloria Perazzoli · 3 shared papers, 2019–2021 · strength 0.35
  3. Consolación Melguizo Alonso · 3 shared papers, 2019–2021 · strength 0.35
  4. Jose Carlos Prados · 3 shared papers, 2019–2021 · strength 0.35
  5. Raúl Ortíz · 1 shared paper, 2021 · strength 0.14
  6. Pablo Redruello Guerrero · 1 shared paper, 2020 · strength 0.11
  7. Antonio Jesús Láinez Ramos‐Bossini · 1 shared paper, 2020 · strength 0.11
  8. Cristina Jiménez‐Luna · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.